Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series

References

Page 1

	Year	Citations
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren Mason, Martin J. van den Bent, New England Journal of Medicine	2005	21K
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Patrick Y. Wen, David R. Macdonald, David A. Reardon, Journal of Clinical Oncology EngineeringHigh-grade GliomasBrain LesionResponse AssessmentGlioma	2010	3.7K
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, New England Journal of Medicine	2014	2.7K
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma Olivier Chinot, Wolfgang Wick, Warren Mason, New England Journal of Medicine	2014	2.4K
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Dmitry I. Gabrilovich, Hailei L. Chen, Khaled R. Girgis, Nature Medicine Endothelial Cell PathobiologyHuman TumorsAngiogenesisImmunologyVascular Biology	1996	2K
VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer Magali Terme, Simon Pernot, Elie Marcheteau, Cancer Research Treg InductionTreg ProliferationMedicineImmunologyPathology	2012	638
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression Joyce E. Ohm, Dmitry I. Gabrilovich, Gregory D. Sempowski, Blood	2003	526
Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma Tracy T. Batchelor, Dan G. Duda, Emmanuelle di Tomaso, Journal of Clinical Oncology	2010	513
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice Rupal Ramakrishnan, Deepak Assudani, Srinivas Nagaraj, Journal of Clinical Investigation Tumor ImmunologyCancer ImmunosurveillanceCancer TherapeuticsMedicineImmunology	2010	456
Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth Petra Hamerlik, Justin D. Lathia, Rikke Rasmussen, The Journal of Experimental Medicine	2012	393

Page 1